https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-12-10 / Br. J. Cancer 2020 Jan;122(1):111-120
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-12-10 / Br. J. Cancer 2020 Jan;122(1):111-1202019-12-10 00:00:002019-12-10 00:00:00Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-21 / World J. Gastroenterol. 2019 Jul;25(27):3649-3663
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-21 / World J. Gastroenterol. 2019 Jul;25(27):3649-36632019-07-21 00:00:002019-07-21 00:00:00Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-07 / World J. Gastroenterol. 2019 Jul;25(25):3151-3167
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-07 / World J. Gastroenterol. 2019 Jul;25(25):3151-31672019-07-07 00:00:002019-07-07 00:00:00Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-28 / World J. Gastroenterol. 2019 Jun;25(24):2977-2989
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-28 / World J. Gastroenterol. 2019 Jun;25(24):2977-29892019-06-28 00:00:002019-06-28 00:00:00Immunotherapy for hepatocellular carcinoma: Current and future
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-01 / Stem Cells Int 2019;2019:5680327
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-01 / Stem Cells Int 2019;2019:56803272019-04-01 00:00:002019-04-01 00:00:00A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-07-30 / Clin. Exp. Med. 2018 Nov;18(4):535-546
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-07-30 / Clin. Exp. Med. 2018 Nov;18(4):535-5462018-07-30 00:00:002018-07-30 00:00:00Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-04-20 / Oncol Res Treat 2018;41(5):292-297
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-04-20 / Oncol Res Treat 2018;41(5):292-2972018-04-20 00:00:002020-12-07 09:37:23Immunotherapy of Hepatocellular Carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-03-26 / J Immunol Res 2018;2018:8740976
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-03-26 / J Immunol Res 2018;2018:87409762018-03-26 00:00:002018-03-26 00:00:00Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-01-03 / PLoS ONE 2018;13(1):e0190638
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-01-03 / PLoS ONE 2018;13(1):e01906382018-01-03 00:00:002020-01-08 10:08:47EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-01 / Am J Cancer Res 2017;7(10):2091-2102
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-01 / Am J Cancer Res 2017;7(10):2091-21022017-10-01 00:00:002019-02-15 08:47:56Dendritic cells based immunotherapy
